Imvotamab is a bispecific immunoglobulin M (IgM) antibody targeting CD20 and CD3. It induces T cell activation while preventing excessive stimulation and potential down-regulation of immune responses. This dual-action mechanism makes Imvotamab a valuable tool for research on B-cell malignancies, including multiple myeloma and non-Hodgkin's lymphoma, facilitating studies on immune modulation and therapeutic interventions.
Imvotamab is a bispecific immunoglobulin M (IgM) antibody targeting CD20 and CD3. It induces T cell activation while preventing excessive stimulation and potential down-regulation of immune responses. This dual-action mechanism makes Imvotamab a valuable tool for research on B-cell malignancies, including multiple myeloma and non-Hodgkin's lymphoma, facilitating studies on immune modulation and therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
